A Phase II Open Label Study to Assess the Efficacy and Safety of Gemcitabine & Nab-Paclitaxel (Abraxane With or Without OSHD (2-0, 3-0 Desulfated Heparin) as First Line Treatment of Metastatic Pancreatic Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/12 → 2/28/14

Funding

  • ParinGenix, Inc ( Award # ): $23,443.75